!
!
Sign in / Join ICS
Home
OnabotulinumtoxinA Improves Urodynamic Outcomes in Patients with Neurogenic Detrusor Overactivity
Rovner E
1
, Dmochowski R
2
, Chapple C R
3
, Thompson C
4
, Lam W
4
, Haag-Molkenteller C
4
Abstract Category
Detrusor Overactivity
Abstract 337
Non-Discussion Posters
Scientific Non Discussion Poster Session 29
1.
MUSC Health Urology Services, Charleston, SC, USA,
2.
Vanderbilt University Medical Center, Nashville, TN, USA,
3.
Royal Hallamshire Hospital, Sheffield, UK,
4.
Allergan, Inc., Irvine, CA, USA
Links
Abstract PDF
Edit Abstract
Abstract Centre
Abstract
22/04/2024 06:09:56